Search

Jean F. Voltaire

Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )

Most Active Art Unit
2466
Art Unit(s)
2466, 2417
Total Applications
487
Issued Applications
381
Pending Applications
55
Abandoned Applications
68

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5010561 [patent_doc_number] => 20070281040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'COMBINATION THERAPY OF HEDGEHOG INHIBITORS, RADIATION AND CHEMOTHERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 11/576310 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11534 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20070281040.pdf [firstpage_image] =>[orig_patent_app_number] => 11576310 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/576310
COMBINATION THERAPY OF HEDGEHOG INHIBITORS, RADIATION AND CHEMOTHERAPEUTIC AGENTS Sep 29, 2005 Abandoned
Array ( [id] => 4803616 [patent_doc_number] => 20080015205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Cancer Combination Therapy Comprising Azd2171 and Imatinib' [patent_app_type] => utility [patent_app_number] => 11/663912 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7930 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015205.pdf [firstpage_image] =>[orig_patent_app_number] => 11663912 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/663912
Cancer Combination Therapy Comprising Azd2171 and Imatinib Sep 22, 2005 Abandoned
Array ( [id] => 5801664 [patent_doc_number] => 20060035981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Inhibition of anaerobic glucose metabolism and corresponding composition as a natural non-toxic approach to cancer treatment' [patent_app_type] => utility [patent_app_number] => 11/233279 [patent_app_country] => US [patent_app_date] => 2005-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12768 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035981.pdf [firstpage_image] =>[orig_patent_app_number] => 11233279 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/233279
Inhibition of anaerobic glucose metabolism and corresponding composition as a natural non-toxic approach to cancer treatment Sep 19, 2005 Abandoned
Array ( [id] => 5415976 [patent_doc_number] => 20090041863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Use of GSK3 inhibitors in combination with radiation therapies' [patent_app_type] => utility [patent_app_number] => 11/663314 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24044 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041863.pdf [firstpage_image] =>[orig_patent_app_number] => 11663314 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/663314
Use of GSK3 inhibitors in combination with radiation therapies Sep 18, 2005 Issued
Array ( [id] => 5638110 [patent_doc_number] => 20060069084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Methods of inhibiting kinases' [patent_app_type] => utility [patent_app_number] => 11/223633 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9014 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069084.pdf [firstpage_image] =>[orig_patent_app_number] => 11223633 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/223633
Methods of inhibiting kinases Sep 8, 2005 Abandoned
Array ( [id] => 5131599 [patent_doc_number] => 20070207996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Novel Compositions And Methods Of Treatment' [patent_app_type] => utility [patent_app_number] => 11/660460 [patent_app_country] => US [patent_app_date] => 2005-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22049 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207996.pdf [firstpage_image] =>[orig_patent_app_number] => 11660460 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/660460
Novel Compositions And Methods Of Treatment Aug 29, 2005 Abandoned
Array ( [id] => 5814976 [patent_doc_number] => 20060084660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Calcium channel blockers comprising two benzhydril moieties' [patent_app_type] => utility [patent_app_number] => 11/214218 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9084 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084660.pdf [firstpage_image] =>[orig_patent_app_number] => 11214218 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/214218
Calcium channel blockers comprising two benzhydril moieties Aug 28, 2005 Abandoned
Array ( [id] => 6978631 [patent_doc_number] => 20050288349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Cancer treatments and pharmaceutical compositions therefor' [patent_app_type] => utility [patent_app_number] => 11/212300 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3843 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288349.pdf [firstpage_image] =>[orig_patent_app_number] => 11212300 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/212300
Cancer treatments and pharmaceutical compositions therefor Aug 25, 2005 Abandoned
Array ( [id] => 4999379 [patent_doc_number] => 20070042013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Long acting injectable formulations' [patent_app_type] => utility [patent_app_number] => 11/207980 [patent_app_country] => US [patent_app_date] => 2005-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20515 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042013.pdf [firstpage_image] =>[orig_patent_app_number] => 11207980 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/207980
Long acting injectable formulations Aug 18, 2005 Issued
Array ( [id] => 5010549 [patent_doc_number] => 20070281028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Drug Delivery of a Cox Inhibitor from Embolic Agents' [patent_app_type] => utility [patent_app_number] => 11/573172 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12678 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20070281028.pdf [firstpage_image] =>[orig_patent_app_number] => 11573172 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/573172
Drug Delivery of a Cox Inhibitor from Embolic Agents Aug 3, 2005 Abandoned
Array ( [id] => 4814044 [patent_doc_number] => 20080194675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Mixture of Catechins or Rather Polyphenols Extracted from Chinese Green Tea or Other Vegetables for the Prevention of Prostate Cancer and for the Treatment of Prostate Hypertrophy (Bph)' [patent_app_type] => utility [patent_app_number] => 11/658614 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3117 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194675.pdf [firstpage_image] =>[orig_patent_app_number] => 11658614 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658614
Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (BPH) Jul 20, 2005 Issued
Array ( [id] => 7550776 [patent_doc_number] => 08063109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones' [patent_app_type] => utility [patent_app_number] => 11/658054 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16847 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063109.pdf [firstpage_image] =>[orig_patent_app_number] => 11658054 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658054
Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones Jul 14, 2005 Issued
Array ( [id] => 4760024 [patent_doc_number] => 20080312250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Combination Comprising a Bcrp Inhibitor and 4- (4-Methylpiperazin-1-Ylmethyl)-N-[4-Methyl-3- (4-Pyridin-3-Yl) Pyrimidin-2-Ylamino) Phenyl] -Benzamide' [patent_app_type] => utility [patent_app_number] => 11/570888 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4457 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312250.pdf [firstpage_image] =>[orig_patent_app_number] => 11570888 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/570888
Combination Comprising a Bcrp Inhibitor and 4- (4-Methylpiperazin-1-Ylmethyl)-N-[4-Methyl-3- (4-Pyridin-3-Yl) Pyrimidin-2-Ylamino) Phenyl] -Benzamide Jun 29, 2005 Abandoned
Array ( [id] => 5771861 [patent_doc_number] => 20050267201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same' [patent_app_type] => utility [patent_app_number] => 11/165896 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7993 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267201.pdf [firstpage_image] =>[orig_patent_app_number] => 11165896 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/165896
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same Jun 23, 2005 Abandoned
Array ( [id] => 5688986 [patent_doc_number] => 20060287301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Novel formulations for phenothiazines, including fluphenazine and its derivatives' [patent_app_type] => utility [patent_app_number] => 11/156016 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11615 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287301.pdf [firstpage_image] =>[orig_patent_app_number] => 11156016 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/156016
Novel formulations for phenothiazines, including fluphenazine and its derivatives Jun 16, 2005 Abandoned
Array ( [id] => 7250862 [patent_doc_number] => 20050272773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Use of R (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-flurophenyl)-ethyl]-4- piperidinemethanol for the treatment of sleep disorders and process for making pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 11/149521 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6466 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272773.pdf [firstpage_image] =>[orig_patent_app_number] => 11149521 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/149521
Use of R (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-flurophenyl)-ethyl]-4- piperidinemethanol for the treatment of sleep disorders and process for making pharmaceutical composition Jun 9, 2005 Abandoned
Array ( [id] => 6604751 [patent_doc_number] => 20100063074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Cancer Treatment Method' [patent_app_type] => utility [patent_app_number] => 11/569877 [patent_app_country] => US [patent_app_date] => 2005-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11717 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063074.pdf [firstpage_image] =>[orig_patent_app_number] => 11569877 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/569877
Cancer Treatment Method May 31, 2005 Abandoned
Array ( [id] => 211564 [patent_doc_number] => 07622470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin' [patent_app_type] => utility [patent_app_number] => 11/141868 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 3532 [patent_no_of_claims] => 161 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622470.pdf [firstpage_image] =>[orig_patent_app_number] => 11141868 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/141868
Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin May 30, 2005 Issued
Array ( [id] => 7172292 [patent_doc_number] => 20050203060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Methods of using thalidomide in combination with irinotecan' [patent_app_type] => utility [patent_app_number] => 11/126315 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7847 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203060.pdf [firstpage_image] =>[orig_patent_app_number] => 11126315 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/126315
Methods of using thalidomide in combination with irinotecan May 10, 2005 Issued
Array ( [id] => 112915 [patent_doc_number] => 07714026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Pharmaceutical composition containing bakuchiol for treating woman osteoporosis' [patent_app_type] => utility [patent_app_number] => 11/126234 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3691 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/714/07714026.pdf [firstpage_image] =>[orig_patent_app_number] => 11126234 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/126234
Pharmaceutical composition containing bakuchiol for treating woman osteoporosis May 10, 2005 Issued
Menu